Wed, December 7, 2016
Tue, December 6, 2016
Mon, December 5, 2016

Annabel Samimy Maintained (TXMD) at Strong Buy with Increased Target to $17 on, Dec 6th, 2016

Annabel Samimy of Stifel, Maintained "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Increased Target from $14 to $17 on, Dec 6th, 2016.

Annabel has made no other calls on TXMD in the last 4 months.



There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, 0 agree with Annabel's Rating of Hold.



This is the rating of the analyst that currently disagrees with Annabel


  • Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $12 on, Tuesday, November 22nd, 2016